DRS293746_1.jpg

Syncapone 150 Tablet

Therapeutic Class: NEURO CNS
Get Quote

Syncapone 150 Tablet is a combination of three medicines: Levodopa, Carbidopa and Entacapone which treat Parkinsonism.tLevodopa is a Carbidopa precursor which gets converted to dopamine, a chemical messenger that controls movement in the brain. Carbidopa is a peripheral decarboxylase inhibitor which prevents the breakdown of Levodopa allowing it to enter the brain and increase dopamine levels. Entacapone is COMT inhibitor which causes higher and more sustained levels of levodopa in blood, leading to greater relief from the symptoms of Parkinson?s disease.

Salt Composition: Levodopa (150mg) + Carbidopa (37.5mg) + Entacapone (200mg)
Strength: Levodopa (150mg) + Carbidopa (37.5mg) + Entacapone (200mg)
Pack Size: strip of 10 tablets
Uses: Parkinson's disease
Table Header
Salt Composition
Levodopa (150mg) + Carbidopa (37.5mg) + Entacapone (200mg)
Strength
Levodopa (150mg) + Carbidopa (37.5mg) + Entacapone (200mg)
Pack Size
strip of 10 tablets
Uses
Parkinson’s disease
DISCLAIMER
Niche Formulations (www.nicheformulations.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India. Product is supplied for Tenders/ Emergency imports/ Unlicensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Product names, logos, brands and other trademarks featured or referred to are the property of their respective Trademark Holders. The information provided here is for Informational purposes only.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories
error:

Select at least 2 products
to compare